The B6

The B6. Nrf2/lpr/lprmice died at younger ages than the other three genotypes of mice with statistical significance (p=0. 0036). == Figure 1 . cytokines were dramatically increased in these double-mutant mice. We also demonstrated that nave T cells from the double-mutant mice showed significantly increased differentiation into Th17 cellsin vitro, with decreased expression from the Th17 differentiation suppressorSocs3and increased phosphorylation of STAT3. Our results demonstrated thatNrf2deficiency promoted Th17 differentiation and function during LN development. Moreover, our results suggested that the regulation of Th17 differentiation via NRF2 could be a therapeutic target intended for the treatment of subclinical LN patients. Lupus nephritis (LN) is the major clinical manifestation of systemic lupus erythematosus (SLE). SLE is a complicated autoimmune disease that is characterised by the production of autoantibodies, systemic inflammation, and damage to vessels and organs1. SLE is a multifactorial disease caused by genetic and environmental factors. Many SLE susceptibility genes are responsible intended for maintaining immune tolerance and homeostasis, such as antigen digesting and demonstration, clearance of apoptotic debris, leukocyte cell surface receptors, and cell signalling and gene transcription molecules2, a few, 4. The pathogenesis of LN involves abnormal B and T cell responses, which promote the production of autoantibodies and immune complex deposits in the kidney and other organs5. Recent studies have found that T cells are primarily responsible for the pathogenesis of LN, including the regulation of B cell responses and the production of autoantibodies, the modulation and differentiation of T helper (Th) cell and effector cell expansion and function, and the activation of SU 3327 macrophages and natural killer cell functions5, 6. Th cells, which are central regulators of adaptive immune responses, play a crucial role in the SU 3327 pathogenesis of SLE by regulating the interactions between other cells and contributing to the production of immunomodulatory cytokines4. Upon antigen stimulation, nave CD4+T cells differentiate into different lineages of Th cells, including Th1, Th2, Th17, Th9, Th22, and Treg cells, according to the types of cytokines they are stimulated by7. In particular, Th17 cells, which produce the pro-inflammatory cytokine interleukin (IL)-17, are important intended for the pathogenesis of SLE8, 9, 10. Patients with SLE have higher levels of IL-17 in serum compared to healthy controls, and an increased amount of IL-17-producing T cells in peripheral blood11, 12, 13. B6/lprmice deficient in IL-23 signalling were resistant to the development of LN and showed deficient Th17 development14. Th17 also co-regulates the pathogenesis of SLE together with type I interferon15, which regulates the germinal centre reactions by IL-21- and IL-17-dependent follicular Th cells in BXD2 mice16, 17, 18. It is well known that Th17 cells regulate SLE pathogenesis through multiple mechanisms19. Nuclear element erythroid 2-related factor 2 (NRF2) is a basic leucine zipper transcription factor and is essential for protecting cells against oxidative stress20, 21. NRF2 acts through the antioxidant response element SU 3327 (ARE)/electrophile response element (EpRE) to regulate the expression of antioxidative enzymes and coordinate a wide range of responses to oxidative damage resulting from electrophiles and reactive oxygen species (ROS)20, 21. Nrf2gene variation Rabbit Polyclonal to PKC zeta (phospho-Thr410) is associated with LN in childhood-onset SLE22. A GWAS analysis also defined theNrf2locus as a region associated with susceptibility to SLE23. Nrf2-null mice developed a lupus-like nephritis syndrome in an age-dependent manner or when treated with pristane induction methods24, 25, 26. Prior studies from both human and murine models reported that NRF2 was involved in the pathogenesis of SLE, but the function of NRF2 in the development of LN is still unclear. To further understand the mechanisms of how immune homeostasis and immune compounds are affected byNrf2deficiency, and howNrf2deficiency raises susceptibility to LN, we producedNrf2/lpr/lprmice with a C57BL/6 background (designated as B6. Nrf2/lpr/lpr) to observe the clinical development of LN. The B6/lprmice, which carried aFasgene mutation and a defect in FAS-mediated apoptosis, developed lupus-like autoimmune manifestations27. We found that the B6. Nrf2/lpr/lprmice developed significant LN with an increased abundance of Th17 cells and a raised level of serum IL-17. Our results suggested that elevated oxidative.